TPST   $1.09  -5.22% Market Closed After Close 1.1 0.92%

Tempest Therapeutics Inc
Total Cash 31.12M
totalCashPerShare 1.235
EBITDA -31.25M
Total Debt 20.25M
quickRatio 2.138
currentRatio 2.167
Total Revenue
debtToEquity 119.576
Revenue/Share
ROA -0.54282004
ROE -2.8926198
grossProfits
freeCashflow -15.20M
operatingCashflow -25.36M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 18.62M
forwardPE -0.8043478
floatShares 21.51M
sharesOutstanding 25.21M
sharesShort 1.86M
sharesShortPriorMonth 2.05M
dateShortInterest
sharesPercentSharesOut 0.07%
heldPercentInsiders 0.00%
heldPercentInstitutions 0.22%
Short Ratio help_outline 5.12%
shortPercentOfFloat 0.09%
impliedSharesOutstanding
bookValue 0.692
Price To Book help_outline 1.60
earningsQuarterlyGrowth
netIncomeToCommon -31.75M
trailingEps -1.60%
forwardEps -1.38%
enterpriseToEbitda -0.60
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.36 3Q 2024
institutionsCount 28
lastUpdated Oct. 17, 2024, 12:05 a.m.